National and Kapodistrian University of Athens
Θεραπευτική αναστολή του πυρηνικού παράγοντα ΚΒ σε πειραματική χημική καρκινογένεση του πνεύμονα
Abstract
dc:descriptionBackground: We have previously shown that airway epithelial nuclear factor (NF)-κB activation promotes urethane-induced lung inflammation and carcinogenesis. The proteasome inhibitor bortezomib blocks NF-κB in various cell types. Also tumor necrosis factor (TNF) has been implicated in inflammation-associated tumor progression. Although multiple reports identified a role for TNF signaling in established cancers, few studies have assessed the impact of TNF blockade on early tumor formation promotion.Aims: To determine the effects of bortezomib on urethane-induced lung inflammation and carcinogenesis. To explore the effects of TNF neutralization in a preclinical mouse model of lung carcinogenesis.Methods: For induction of multi-stage lung adenocarcinogenesis, Balb/c mice received four weekly intraperitoneal(IP) injections of urethane (1g/kg). Specifically designed groups of mice received IP bi-weekly bortezomib (1mg/kg) and soluble TNF receptor (etanercept; 10 mg/kg), during tumor initiation, progression, or continuously. Primary end-points were lung tumor number, size, and histologic distribution at 24 weeks. Lung oncogenesis for TNF receptor was assessed after 8months. In separate short-term studies, Balb/c mice (n=21) received a single control or urethane injection followed by twice-weekly intraperitoneal control or sTNFR:Fc injections. Lung inflammation was assessed after 1 week.Results: Short-term bortezomib treatment (tumor initiation, progression) had no profound effect on the number, size, and type of lung tumors. However, continuous bortezomib treatment resulted in markedly increased lung tumor number and size after 24 weeks, without affecting the histologic distribution of lung neoplastic lesions between hyperplasia, adenoma, and adenocarcinoma. Studies of urethane and bortezomib-treated mice at early time points revealed that bortezomib suppressed the acute, but augmented and perpetuated the chronic inflammatory response to urethane. For sTNFR:Fc treatment we found that - during tumor initiation/promotion resulted in a significant reduction of tumor number but not dimensions. However, sTNFR:Fc administered during tumor progression did not impact tumor multiplicity but significantly decreased tumor diameter. Continued sTNFR:Fc administration was effective in halting both respiratory tumor formation and progression in response to urethane. This favorable impact was associated with impaired cellular proliferation and new vessel formation in lung tumors. In addition, TNF neutralization altered the lung inflammatory response to urethane, evidenced by reductions in TNF and macrophage and increases in interferon γ and interleukin 10 content of the air spaces. sTNFR:Fc treatment of RAW264.7 macrophages downregulated TNF and enhanced interferon γ and interleukin 10 expression.Conclusions: Prolonged proteasome inhibition enhances chemical lung carcinogenesis in mice and may promote lung cancer progression in humans. TNF neutralization is effective against urethane-induced lung oncogenesis in mice and could present a lung chemoprevention strategy worth testing clinically.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karabela, Keparesia-Sophia
- Καράμπελα, Κυπαρισσία-Σοφία
Subjects
dc:subject × 15Rights
dc:rights- Statement dc:rights
-
- BY_NC_ND
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38161